The Effects of Fluoxetine and Agomelatine on Neurocognitive Functions and Sleep in Patients with Major Depressive Disorder.

Esat Fahri Aydın Mustafa Güleç Elif Oral Ali Gökhan Daloğlu

Published in: Psychiatry and clinical psychopharmacology (2024)

Both drugs improved the neurocognitive functioning in the participants. However, the better effect of agomelatine in improving the TMT-B scores suggests that it is a suitable option for MDD patients with noticeable executive disturbances.

Keyphrases

major depressive disorder
bipolar disorder
physical activity
sleep quality
working memory
drug induced